Review




Structured Review

Procell Inc synovial mesenchymal stem cells
A: Morphological characteristics of SMSCs observed under an inverted microscope. Representative images from three independent experiments are shown (n = 3) (scale bar = 100 μm). B: Flow cytometric analysis confirming the SMSC phenotype. The cells were highly positive for the <t>mesenchymal</t> marker CD29, and negative for the hematopoietic markers CD34 and CD45. This profile (CD29 + CD34–CD45–) is consistent with the ISCT criteria for mesenchymal stem cells (n = 3).
Synovial Mesenchymal Stem Cells, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synovial+mesenchymal+stem+cells/pmc13200082-53-12-29?v=Procell+Inc
Average 86 stars, based on 1 article reviews
synovial mesenchymal stem cells - by Bioz Stars, 2026-07
86/100 stars

Images

1) Product Images from "Effects and mechanisms of synovial mesenchymal stem cell–derived extracellular vesicular LncRNA-SNHG14 on chondrocyte injury"

Article Title: Effects and mechanisms of synovial mesenchymal stem cell–derived extracellular vesicular LncRNA-SNHG14 on chondrocyte injury

Journal: Regenerative Therapy

doi: 10.1016/j.reth.2026.101122

A: Morphological characteristics of SMSCs observed under an inverted microscope. Representative images from three independent experiments are shown (n = 3) (scale bar = 100 μm). B: Flow cytometric analysis confirming the SMSC phenotype. The cells were highly positive for the mesenchymal marker CD29, and negative for the hematopoietic markers CD34 and CD45. This profile (CD29 + CD34–CD45–) is consistent with the ISCT criteria for mesenchymal stem cells (n = 3).
Figure Legend Snippet: A: Morphological characteristics of SMSCs observed under an inverted microscope. Representative images from three independent experiments are shown (n = 3) (scale bar = 100 μm). B: Flow cytometric analysis confirming the SMSC phenotype. The cells were highly positive for the mesenchymal marker CD29, and negative for the hematopoietic markers CD34 and CD45. This profile (CD29 + CD34–CD45–) is consistent with the ISCT criteria for mesenchymal stem cells (n = 3).

Techniques Used: Inverted Microscopy, Marker



Similar Products

86
Procell Inc synovial mesenchymal stem cells
A: Morphological characteristics of SMSCs observed under an inverted microscope. Representative images from three independent experiments are shown (n = 3) (scale bar = 100 μm). B: Flow cytometric analysis confirming the SMSC phenotype. The cells were highly positive for the <t>mesenchymal</t> marker CD29, and negative for the hematopoietic markers CD34 and CD45. This profile (CD29 + CD34–CD45–) is consistent with the ISCT criteria for mesenchymal stem cells (n = 3).
Synovial Mesenchymal Stem Cells, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synovial+mesenchymal+stem+cells/pmc13200082-53-12-29?v=Procell+Inc
Average 86 stars, based on 1 article reviews
synovial mesenchymal stem cells - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

86
Procell Inc mouse synovial mesenchymal stem cells smscs
Anti-ferroptotic effect of Fe 3 O 4 @C nanoparticles via the GPX4/SLC7A11 axis. (A) Schematic illustration of the co-culture system for assessing Fe 3 O 4 @C protective effects. (B) Volcano plot analysis of DEGs in <t>SMSCs</t> between the inflammatory and Fe 3 O 4 @C treatment groups. (C–D) qPCR validation of ferroptosis and inflammatory markers in synoviocytes and chondrocytes under different treatment conditions. DEGs, differentially expressed genes (n = 3). (E–F) Ratio of reduced to oxidized fluorescence intensity of BODIPY 581/591C11 in synoviocytes (E) and chondrocytes (F), demonstrating lipid peroxidation levels (n = 3). (G–H) Total GSH content in synoviocytes (G) and chondrocytes (H), reflecting cellular antioxidant capacity (n = 3).∗( P < 0.05), ∗∗ ( P < 0.01), ∗∗∗( P < 0.001), ∗∗∗∗( P < 0.0001).
Mouse Synovial Mesenchymal Stem Cells Smscs, supplied by Procell Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synovial+mesenchymal+stem+cells/pmc12664475-73-6-16?v=Procell+Inc
Average 86 stars, based on 1 article reviews
mouse synovial mesenchymal stem cells smscs - by Bioz Stars, 2026-07
86/100 stars
  Buy from Supplier

90
Northwell Health Laboratories synovial fluid mesenchymal stem cell-derived exosomes
Anti-ferroptotic effect of Fe 3 O 4 @C nanoparticles via the GPX4/SLC7A11 axis. (A) Schematic illustration of the co-culture system for assessing Fe 3 O 4 @C protective effects. (B) Volcano plot analysis of DEGs in <t>SMSCs</t> between the inflammatory and Fe 3 O 4 @C treatment groups. (C–D) qPCR validation of ferroptosis and inflammatory markers in synoviocytes and chondrocytes under different treatment conditions. DEGs, differentially expressed genes (n = 3). (E–F) Ratio of reduced to oxidized fluorescence intensity of BODIPY 581/591C11 in synoviocytes (E) and chondrocytes (F), demonstrating lipid peroxidation levels (n = 3). (G–H) Total GSH content in synoviocytes (G) and chondrocytes (H), reflecting cellular antioxidant capacity (n = 3).∗( P < 0.05), ∗∗ ( P < 0.01), ∗∗∗( P < 0.001), ∗∗∗∗( P < 0.0001).
Synovial Fluid Mesenchymal Stem Cell Derived Exosomes, supplied by Northwell Health Laboratories, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synovial+mesenchymal+stem+cells/pm36918973-445-5-40?v=Northwell+Health+Laboratories
Average 90 stars, based on 1 article reviews
synovial fluid mesenchymal stem cell-derived exosomes - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

90
Cyagen Biosciences synovial mesenchymal stem cell chondrogenic differentiation basal medium
Anti-ferroptotic effect of Fe 3 O 4 @C nanoparticles via the GPX4/SLC7A11 axis. (A) Schematic illustration of the co-culture system for assessing Fe 3 O 4 @C protective effects. (B) Volcano plot analysis of DEGs in <t>SMSCs</t> between the inflammatory and Fe 3 O 4 @C treatment groups. (C–D) qPCR validation of ferroptosis and inflammatory markers in synoviocytes and chondrocytes under different treatment conditions. DEGs, differentially expressed genes (n = 3). (E–F) Ratio of reduced to oxidized fluorescence intensity of BODIPY 581/591C11 in synoviocytes (E) and chondrocytes (F), demonstrating lipid peroxidation levels (n = 3). (G–H) Total GSH content in synoviocytes (G) and chondrocytes (H), reflecting cellular antioxidant capacity (n = 3).∗( P < 0.05), ∗∗ ( P < 0.01), ∗∗∗( P < 0.001), ∗∗∗∗( P < 0.0001).
Synovial Mesenchymal Stem Cell Chondrogenic Differentiation Basal Medium, supplied by Cyagen Biosciences, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/synovial+mesenchymal+stem+cells/ppr0231617-104-7-14?v=Cyagen+Biosciences
Average 90 stars, based on 1 article reviews
synovial mesenchymal stem cell chondrogenic differentiation basal medium - by Bioz Stars, 2026-07
90/100 stars
  Buy from Supplier

Image Search Results


A: Morphological characteristics of SMSCs observed under an inverted microscope. Representative images from three independent experiments are shown (n = 3) (scale bar = 100 μm). B: Flow cytometric analysis confirming the SMSC phenotype. The cells were highly positive for the mesenchymal marker CD29, and negative for the hematopoietic markers CD34 and CD45. This profile (CD29 + CD34–CD45–) is consistent with the ISCT criteria for mesenchymal stem cells (n = 3).

Journal: Regenerative Therapy

Article Title: Effects and mechanisms of synovial mesenchymal stem cell–derived extracellular vesicular LncRNA-SNHG14 on chondrocyte injury

doi: 10.1016/j.reth.2026.101122

Figure Lengend Snippet: A: Morphological characteristics of SMSCs observed under an inverted microscope. Representative images from three independent experiments are shown (n = 3) (scale bar = 100 μm). B: Flow cytometric analysis confirming the SMSC phenotype. The cells were highly positive for the mesenchymal marker CD29, and negative for the hematopoietic markers CD34 and CD45. This profile (CD29 + CD34–CD45–) is consistent with the ISCT criteria for mesenchymal stem cells (n = 3).

Article Snippet: Primary rat chondrocytes (Catalog No. CP-R087, 5 × 10 5 Cells/T25) and synovial mesenchymal stem cells (SMSC, Catalog No. CP-R304, 5 × 10 5 Cells/T25) were purchased from Wuhan Procell Life Science & Technology Co., Ltd.

Techniques: Inverted Microscopy, Marker

Anti-ferroptotic effect of Fe 3 O 4 @C nanoparticles via the GPX4/SLC7A11 axis. (A) Schematic illustration of the co-culture system for assessing Fe 3 O 4 @C protective effects. (B) Volcano plot analysis of DEGs in SMSCs between the inflammatory and Fe 3 O 4 @C treatment groups. (C–D) qPCR validation of ferroptosis and inflammatory markers in synoviocytes and chondrocytes under different treatment conditions. DEGs, differentially expressed genes (n = 3). (E–F) Ratio of reduced to oxidized fluorescence intensity of BODIPY 581/591C11 in synoviocytes (E) and chondrocytes (F), demonstrating lipid peroxidation levels (n = 3). (G–H) Total GSH content in synoviocytes (G) and chondrocytes (H), reflecting cellular antioxidant capacity (n = 3).∗( P < 0.05), ∗∗ ( P < 0.01), ∗∗∗( P < 0.001), ∗∗∗∗( P < 0.0001).

Journal: Materials Today Bio

Article Title: Ultra-small iron-based nanoparticles Mitigate rheumatoid arthritis inflammation via macrophage Repolarization and SLC7A11/GPX4-mediated ferroptosis inhibition

doi: 10.1016/j.mtbio.2025.102551

Figure Lengend Snippet: Anti-ferroptotic effect of Fe 3 O 4 @C nanoparticles via the GPX4/SLC7A11 axis. (A) Schematic illustration of the co-culture system for assessing Fe 3 O 4 @C protective effects. (B) Volcano plot analysis of DEGs in SMSCs between the inflammatory and Fe 3 O 4 @C treatment groups. (C–D) qPCR validation of ferroptosis and inflammatory markers in synoviocytes and chondrocytes under different treatment conditions. DEGs, differentially expressed genes (n = 3). (E–F) Ratio of reduced to oxidized fluorescence intensity of BODIPY 581/591C11 in synoviocytes (E) and chondrocytes (F), demonstrating lipid peroxidation levels (n = 3). (G–H) Total GSH content in synoviocytes (G) and chondrocytes (H), reflecting cellular antioxidant capacity (n = 3).∗( P < 0.05), ∗∗ ( P < 0.01), ∗∗∗( P < 0.001), ∗∗∗∗( P < 0.0001).

Article Snippet: The RAW264.7 macrophage cell line and mouse synovial mesenchymal stem cells (SMSCs) were obtained commercially from Procell (Wuhan, China).

Techniques: Co-Culture Assay, Biomarker Discovery, Fluorescence